OTCMKTS:CHGCY Chugai Pharmaceutical 10/25/2024 Earnings Results & Report $22.18 -0.20 (-0.89%) As of 04:00 PM Eastern Chugai Pharmaceutical reported earnings on October 25, 2024. The company reported EPS of $0.22, while revenue was $2.12 billion. Research:ProfileEarnings HistoryForecast Earnings Announcement Details Report DateOctober 25, 2024TimeBefore Market Opens Chugai Pharmaceutical EPS ResultsActual EPS$0.22Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AChugai Pharmaceutical Revenue ResultsActual Revenue$2.12 billionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Chugai Pharmaceutical Earnings FAQ Did Chugai Pharmaceutical beat earnings estimates for the quarter? Chugai Pharmaceutical (OTCMKTS:CHGCY) reported earnings of $0.22 per share for the quarter. The report was announced on Friday, October 25, 2024. What was Chugai Pharmaceutical's revenue for the quarter? Chugai Pharmaceutical reported revenue of $2.12 billion for the quarter. Chugai Pharmaceutical Earnings HeadlinesChugai Pharmaceutical Co. - Depositary receipt price target decreased by 15.22% to $26.89October 23, 2026 | msn.comCHGCY - Chugai Pharmaceutical Co., Ltd.October 12, 2026 | seekingalpha.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 12 at 1:00 AM | Behind the Markets (Ad)Chugai Pharmaceutical Co. Ltd. ADRAugust 19, 2026 | wsj.comChugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call TranscriptJuly 24, 2026 | seekingalpha.comChugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call TranscriptJanuary 29, 2026 | seekingalpha.comSee More Chugai Pharmaceutical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Chugai Pharmaceutical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Chugai Pharmaceutical and other key companies, straight to your email. Email Address About Chugai PharmaceuticalChugai Pharmaceutical (OTCMKTS:CHGCY) is a Japan-based research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its work focuses on areas including oncology, immunology, hematology and neuroscience, and its portfolio includes biologic and antibody-based medicines as well as other pharmaceutical products. The company was established in Japan in 1925 and is headquartered in Tokyo. Since 2002, Chugai has been part of the Roche Group through a strategic alliance, while continuing to operate as a Japan-based pharmaceutical company. Chugai serves patients and healthcare providers in Japan and works with Roche to develop and commercialize medicines internationally. The collaboration combines Chugai’s research and development capabilities with Roche’s global reach.View Chugai Pharmaceutical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
